Grecia - greco - Εθνικός Οργανισμός Φαρμάκων

genepharm ae 18 ΧΛΜ. Λ. ΜΑΡΑΘΩΝΟΣ, 15351 ΠΑΛΛΗΝΗ ΑΤΤΙΚΗΣ 6039336 - sunitinib - caps (ΚΑΨΑΚΙΟ, ΣΚΛΗΡΟ) - 37.5mg/cap - sunitinib 37,5mg - sunitinib

Grecia - greco - Εθνικός Οργανισμός Φαρμάκων

genepharm ae 18 ΧΛΜ. Λ. ΜΑΡΑΘΩΝΟΣ, 15351 ΠΑΛΛΗΝΗ ΑΤΤΙΚΗΣ 6039336 - sunitinib - caps (ΚΑΨΑΚΙΟ, ΣΚΛΗΡΟ) - 50mg/cap - sunitinib 50mg - sunitinib

Grecia - greco - Εθνικός Οργανισμός Φαρμάκων

egis pharmaceuticals plc, budapest (kereszturi), hungary kereszturi ut 30-38,, 1106 budapest x 36-1-265 5555, 5554 - sunitinib - caps (ΚΑΨΑΚΙΟ, ΣΚΛΗΡΟ) - 50mg/cap - sunitinib 50mg - sunitinib

Grecia - greco - Εθνικός Οργανισμός Φαρμάκων

egis pharmaceuticals plc, budapest (kereszturi), hungary kereszturi ut 30-38,, 1106 budapest x 36-1-265 5555, 5554 - sunitinib - caps (ΚΑΨΑΚΙΟ, ΣΚΛΗΡΟ) - 12.5mg/cap - sunitinib 12,5mg - sunitinib

Grecia - greco - Εθνικός Οργανισμός Φαρμάκων

egis pharmaceuticals plc, budapest (kereszturi), hungary kereszturi ut 30-38,, 1106 budapest x 36-1-265 5555, 5554 - sunitinib - caps (ΚΑΨΑΚΙΟ, ΣΚΛΗΡΟ) - 25mg/cap - sunitinib 25mg - sunitinib

Cipro - greco - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

mylan ire healthcare limited (0000010616) unit 35/36, grange parade, baldoyle industrial estate, dublin 13 - a/victoria/2570/2019 (h1n1)pdm09-like strain (a/victoria/2570/2019, ivr-215); a/cambodia/e0826360/2020 (h3n2)-like strain (a/cambodia/e0826360/2020, ivr- 224); b/washington/02/2019-like strain (b/washington/02/2019, wild type) - suspension for injection in pre-filled syringe - a/victoria/2570/2019 (h1n1)pdm09-like strain (a/victoria/2570/2019, ivr-215) (8000004843) 15ug; a/cambodia/e0826360/2020 (h3n2)-like strain (a/cambodia/e0826360/2020, ivr- 224) (8000004845) 15ug; b/washington/02/2019-like strain (b/washington/02/2019, wild type) (8000004816) 15ug - influenza, purified antigen

Grecia - greco - Εθνικός Οργανισμός Φαρμάκων

mylan ire healthcare limited, ireland unit 35/36 grange parade, - dublin 13 - danaparoid sodium - inj.sol (ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ) - 750 anti-xa factor units/0,6ml amp - danaparoid sodium 1.250xa - danaparoid

Unione Europea - greco - EMA (European Medicines Agency)

pfizer limited - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - Αντινεοπλασματικοί παράγοντες - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. experience with sutent as first-line treatment is limited (see section 5.

Cipro - greco - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

remedica ltd (0000003171) aharnon str., lemesos, 3056 - sunitinib - capsule,hard - 12.5mg - sunitinib (8000003189) 12,5mg

Cipro - greco - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

remedica ltd (0000003171) aharnon str., lemesos, 3056 - sunitinib - capsule,hard - 37.5mg - sunitinib (8000003189) 37,5mg